Skip to main content
Clinical Trials/ISRCTN33898123
ISRCTN33898123
Completed
Not Applicable

A randomised double-blind placebo-controlled trial of preemptive analgesia with bupivacaine in patients undergoing mastectomy for carcinoma of the breast

Medical University of Gdansk (Poland)0 sites100 target enrollmentFebruary 22, 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast cancer
Sponsor
Medical University of Gdansk (Poland)
Enrollment
100
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 22, 2010
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Medical University of Gdansk (Poland)

Eligibility Criteria

Inclusion Criteria

  • 1\. Breast cancer patients in disease stage I, II and IIIA without neoadjuvant treatment
  • 2\. Patients qualified for radical modified mastectomy
  • 3\. Informed consent obtained from the patient
  • 4\. Females aged 35 \- 90 years

Exclusion Criteria

  • 1\. No informed consent obtained from the patient
  • 2\. Allergy to bupivacaine or any other local analgesic agent
  • 3\. Allergy to any of the drugs used in the analgesia protocol
  • 4\. Prior surgically treatment for breast cancer
  • 5\. Patient history with treatment of chronic pain
  • 6\. Patients with any psychiatric disorders
  • 7\. Patients weight below 50 kg

Outcomes

Primary Outcomes

Not specified

Similar Trials